# Neuroprotection During Open Heart Surgery

> **NCT04486690** · PHASE3 · COMPLETED · sponsor: **ghada fouad** · enrollment: 50 (actual)

## Conditions studied

- Open Heart Surgery

## Interventions

- **DRUG:** Ketofol (propofol to ketamine ratio 1:1)
- **DRUG:** propofol

## Key facts

- **NCT ID:** NCT04486690
- **Lead sponsor:** ghada fouad
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-01
- **Primary completion:** 2017-06-30
- **Final completion:** 2017-06-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04486690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04486690, "Neuroprotection During Open Heart Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04486690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*